Skip to Main Content

Author Details

George G Klee
Mayo Clinic
1974
239
61
PMIDPaper TitleJournal TitlePublished Year
33306251Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort.BJU Int2021
31603253Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.Prostate2020
31929150The slow releasing hydrogen sulfide donor GYY4137 reduces neointima formation upon FeCl3 injury of the carotid artery in mice.Clin Hemorheol Microcirc2020
33163723Urinary CD80 Discriminates Among Glomerular Disease Types and Reflects Disease Activity.Kidney Int Rep2020
33177066Just an odd rash?BMJ2020
32924989Hydrogen sulfide reduces the activity of human endothelial cells.Clin Hemorheol Microcirc2020
30169553Reference Intervals: Comparison of Calculation Methods and Evaluation of Procedures for Merging Reference Measurements From Two US Medical Centers.Am J Clin Pathol2018
27506603Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference.Clin Chem Lab Med2017
28936267Roles of kallikrein-2 biomarkers (free-hK2 and pro-hK2) for predicting prostate cancer progression-free survival.J Circ Biomark2017
27666762A global multicenter study on reference values: 2. Exploration of sources of variation across the countries.Clin Chim Acta2017
27666761A global multicenter study on reference values: 1. Assessment of methods for derivation and comparison of reference intervals.Clin Chim Acta2017
27743489Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.BJU Int2017
26785381Multiple calibrator measurements improve accuracy and stability estimates of automated assays.Scand J Clin Lab Invest2016
27444747Interleukins 6 and 8 and abdominal fat depots are distinct correlates of lipid moieties in healthy pre- and postmenopausal women.Endocrine2016
25132238The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.J Urol2015
26432404Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation.Cancer Res2015
25463993The prostate health index selectively identifies clinically significant prostate cancer.J Urol2015
24203061Immunological and mass spectrometric assays of SHBG: consistent and inconsistent metabolic associations in healthy men.J Clin Endocrinol Metab2014
25268201Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.Arch Pathol Lab Med2014
25171699Verifying performance characteristics of quantitative analytical systems: calibration verification, linearity, and analytical measurement range.Arch Pathol Lab Med2014
25130957Evaluation of Beckman Coulter DxI 800 immunoassay system using clinically oriented performance goals.Clin Biochem2014
24747109Reprint of "Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits".Clin Chim Acta2014
24746136Immunologic and mass-spectrometric estimates of SHBG concentrations in healthy women.Metabolism2014
24619754Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences.Am J Clin Pathol2014
24362233Influence of analytical bias and imprecision on the number of false positive results using Guideline-Driven Medical Decision Limits.Clin Chim Acta2014
24139354Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.Urology2014
23331729Analytical performance specifications: relating laboratory performance to quality required for intended clinical use.Clin Lab Med2013
23826159Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.PLoS One2013
23969469Category-specific uncertainty modeling in clinical laboratory measurement processes.Clin Chem Lab Med2013
24032487Empiric validation of simulation models for estimating glucose meter performance criteria for moderate levels of glycemic control.Diabetes Technol Ther2013
23633469Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values.Clin Chem Lab Med2013
23633468Utility of a panel of sera for the alignment of test results in the worldwide multicenter study on reference values.Clin Chem Lab Med2013
23770138Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.J Urol2013
23467205Associations of candidate biomarkers of vascular disease with the ankle-brachial index and peripheral arterial disease.Am J Hypertens2013
23525873Defining acceptable limits for the metrological traceability of specific measurands.Clin Chem Lab Med2013
23206426Prospective multicenter evaluation of the Beckman Coulter Prostate Health Index using WHO calibration.J Urol2013
22093189Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.J Urol2012
22960655Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in β cells and mice.Gastroenterology2012
23093083Application of mathematical models of system uncertainty to evaluate the utility of assay calibration protocols.Clin Chem Lab Med2012
22542565Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay.Clin Chim Acta2012
22589488Global methylation profiling for risk prediction of prostate cancer.Clin Cancer Res2012
22247499Candidate serum biomarkers for prostate adenocarcinoma identified by mRNA differences in prostate tissue and verified with protein measurements in tissue and blood.Clin Chem2012
22212966Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.Mayo Clin Proc2012
22386420Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.Urology2012
22093190Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.J Urol2012
21419439A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.J Urol2011
21907119Hereditary hyperferritinemia-cataract syndrome in two large multigenerational American families.J AAPOS2011
21519039Biologic variation of a novel cardiac troponin I assay.Clin Chem2011
21367876Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.Am J Epidemiol2011
21464006[Establishment of outcome-related analytic performance goals].Ann Biol Clin (Paris)2011
  • 1 - 50 of 239

Recommended Authors

University of Texas Health Science Center at San Antonio
Career Start Year 2011
Number of shared co-authors 0
The Hospital for Sick Children, University of Toronto
Career Start Year 2011
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2011
Number of shared co-authors 1
Nationwide Children's Hospital, College of Medicine, The Ohio State University
Career Start Year 2008
Number of shared co-authors 0
University of Pittsburgh School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Ann Robert H. Lurie Childrens Hospital of Chicago
Career Start Year 2000
Number of shared co-authors 0
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 6
University of Louisville
Career Start Year 1991
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Homer Stryker MD School of Medicine, Western Michigan University
Career Start Year 1990
Number of shared co-authors 0
Universite de Paris, U1 INSERM
Career Start Year 1989
Number of shared co-authors 0
Montefiore Medical Center
Career Start Year 1988
Number of shared co-authors 0
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 3
university of california san diego Health, Center for Advanced Laboratory Medicine
Career Start Year 1988
Number of shared co-authors 2
Mayo Clinic
Career Start Year 1986
Number of shared co-authors 23
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 0
Rollins School of Public Health, Emory University School of Medicine
Career Start Year 1984
Number of shared co-authors 0
University of Otago
Career Start Year 1983
Number of shared co-authors 0
University of Maryland School of Medicine, University of Maryland
Career Start Year 1982
Number of shared co-authors 5
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 0
University of Western Australia
Career Start Year 1980
Number of shared co-authors 6
1Emory University
Career Start Year 1980
Number of shared co-authors 1
University of California san francisco
Career Start Year 1979
Number of shared co-authors 3
Tufts Medical Center, United States Tufts Medical Center
Career Start Year 1979
Number of shared co-authors 4
Emory University
Career Start Year 1976
Number of shared co-authors 0
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 1
Health Informatics Institute, University of South Florida
Career Start Year 1971
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1968
Number of shared co-authors 0
and School of Public Health, University of Michigan ann arbor
Career Start Year 1965
Number of shared co-authors 4

Collaborators

Kaiser Permanente Southern California
Co-authored papers 16
Mayo Clinic
Co-authored papers 11
Mayo Clinic College of Medicine
Co-authored papers 11
Mayo Clinic College of Medicine and Science
Co-authored papers 10
Mayo Clinic
Co-authored papers 10
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 9
University of North Carolina at Chapel Hill
Co-authored papers 8
Division of Clinical Chemistry, Johns Hopkins University
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Co-authored papers 6
Mayo Clinic
Co-authored papers 5
Co-authored papers 5
Merck & Co., Inc.
Co-authored papers 5
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 5
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Mayo Clinic
Co-authored papers 4
Co-authored papers 3
Akron City Hospital
Co-authored papers 3
University of Utah Health Sciences Center
Co-authored papers 3
Co-authored papers 3
Co-authored papers 3
Inova Health System
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
School of Public Health, University of Michigan ann arbor
Co-authored papers 3
Mayo Clinic
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
Co-authored papers 2
Center for Epigenetics, Van Andel Research Institute
Co-authored papers 2